Biotechnology - Licensing, Asia-Pacific

Filter

Current filters:

LicensingAsia-Pacific

Popular Filters

1 to 25 of 34 results

Merck Serono signs $232 million deal with Chinese company for BeiGene-290

Merck Serono signs $232 million deal with Chinese company for BeiGene-290

13-11-2013

Merck Serono has signed a global licensing, co-development and commercialization agreement for BeiGene-290…

Asia-PacificBeiGeneBiotechnologyChinaLicensingMerck SeronoOncology

Lundbeck and Otsuka partner on Biotie’s nalmefene in Japan

Lundbeck and Otsuka partner on Biotie’s nalmefene in Japan

31-10-2013

Biotie Therapies says that its partner, Lundbeck has expanded its existing alliance with Otsuka Pharmaceutical…

Asia-PacificBiotechnologyBiotie TherapiesLicensingLundbeckMarkets & MarketingnalmefeneNeurologicalSelincro

Immutep and Eddingpharm sign accord for ImmuFact IMP321 in China

07-10-2013

French biopharma Immutep and Chinese drugmaker Eddingpharm have entered into an agreement for the development,…

Asia-PacificBiotechnologyLicensingMarkets & MarketingOncologyResearch

Sirona Biochem signs LoI with leading Chinese diabetes company

22-08-2013

Canada's Sirona Biotech (TSX VENTURE:SBM) has signed a letter of intent to provide an exclusive license…

Asia-PacificBiotechnologyDiabetesFosun PharmaLicensingPharmaceuticalSGLT2Sirona BiochemWanbang Pharma

AstraZeneca to fork out $815 million for rights to anemia drug candidate

31-07-2013

In yet another move to boost its R&D pipeline, Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered…

Asia-PacificASP1517Astellas PharmaAstraZenecaBiotechnologyFG-4592FibroGenLicensingNephrology and HepatologyNorth AmericaPharmaceuticalResearch

Soligenix collaborates with SciClone in China for SGX942 as oral mucositis therapy

09-07-2013

US clinical-stage biopharma firm Soligenix (OTCQB: SNGX) has entered into a personalized medicine collaboration…

Asia-PacificBiotechnologyLicensingOncologyResearchSciClone PharmaSGX942Soligenix

Pharming and SIPI collaboration includes Ruconest marketing in China

02-07-2013

Dutch biotech company Pharming Group (NYSE Euronext: PHARM) and Shanghai Institute of Pharmaceutical…

Asia-PacificBiotechnologyCardio-vascularLicensingPharmaceuticalPharmingResearchRuconestSinopharm Group

Bristol-Myers and Simcere agree to co-develop/commercialize Orencia SC in China

14-06-2013

US pharma major Bristol-Myers Squibb (NYSE: BMY) and China-based Simcere Pharmaceutical (NYSE: SCR) have…

Anti-Arthritics/RheumaticsAsia-PacificBiotechnologyBristol-Myers SquibbLicensingOrenciaPharmaceuticalSimcere Pharmaceutical

Amgen and Cytokinetics expand omecamtiv mecarbil accord

12-06-2013

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech company, has expanded its strategic…

AmgenAsia-PacificBiotechnologyCardio-vascularCytokineticsLicensingomecamtiv mecarbil

BioLineRx collaborates with Chinese firm on hep C drug BL-8030

11-06-2013

Israeli drug developer BioLineRx (TASE: BLRX) has signed an out-licensing agreement with Jiangsu Chia-tai…

Anti-viralsAsia-PacificBioLineRxBiotechnologyBL-8030Chia-tai Tianqing PharmaceuticalLicensingPharmaceutical

CMC Biologics and RuiYi link on MAb; Deal for Cynviloq rights in EU

14-05-2013

Denmark and USA-based contract manufacturers CMC Biologics has entered into an agreement with China's…

Asia-PacificBiotechnologyCMC BiologicsCynviloqEuropeIGDRASOLLicensingOncologyPharmaceuticalResearchRuiYiSamyang BiopharmaceuticalsSorrento Therapeutics

Third deal for Ascletis, which gains China market rights from Janssen to a clinical stage HIV protease inhibitor

01-05-2013

USA and China-based biotech firm Ascletis Pharmaceuticals says it has licensed development, manufacturing…

Anti-viralsAscletis PharmaceuticalsAsia-PacificBiotechnologyJanssenJohnson & JohnsonLicensingTMC310911

Roche teams up with Ascletis on hep C treatments for China

15-04-2013

Roche (ROG: SIX) has entered a collaboration with Ascletis Pharmaceuticals, a USA- and China-based biotech…

Anti-viralsAscletis PharmaceuticalsAsia-PacificBiotechnologydanoprevirLicensingMarkets & MarketingPharmaceuticalResearchRoche

HUYA Bioscience partners with Shanghai Zhangjiang Biotech Pharmaceutical Base

06-03-2013

HUYA Bioscience International, jointly headquartered in Shanghai, China, and in San Diego, USA, has entered…

Asia-PacificBiotechnologyHUYA BioscienceLicensingPharmaceuticalResearchShanghai Zhangjiang Biotech

CEVEC Pharma signs deal with South Korea's Yuhan

20-12-2012

CEVEC Pharmaceuticals, a German developer of a novel human expression system derived from amniocytes,…

Asia-PacificBiotechnologyCEVEC PharmaceuticalsLicensingResearchYuhan Corp

News briefs on Ipsen/Galderma and YM BioSciences nimotuzumab assets

04-12-2012

French drugmaker Ipsen (Euronext: IPN) and Switzerland-headquartered Galderma have expanded their collaboration…

Asia-PacificBiotechnologyCIMABDysportGaldermaInnoKeys PTEIpsenLicensingnimotuzumabOncologyPharmaceuticalSouth AmericaYM Biosciences

PharmaEssentia gets certain Asian rights to Kinex' dermatology candidate KX01

03-12-2012

USA-based privately-held Kinex Pharmaceuticals has entered a licensing agreement granting Taiwan's PharmaEssentia…

Asia-PacificBiotechnologyDermatologicalsKinex PharmaceuticalsKX01LicensingPharmaEssentia

Alnylam gets upfront $22.5 million in RNAi link with Genzyme

23-10-2012

French drug major Sanofi's (Euronext: SAN) US biotech subsidiary Genzyme has entered into an exclusive…

Alnylam PharmaceuticalsAsia-PacificBiotechnologyGenzymeLicensingPharmaceuticalRare diseasesSanofi

Germany seeks closer partnership with Japan in biopharmaceuticals

08-10-2012

Germany Trade & Invest (GTI) and the Health - Made in Germany initiative will join forces at this year's…

Asia-PacificBiotechnologyEuropeLicensingResearch

Australian Productivity Commission reviews compulsory licensing in the patents system

30-08-2012

The Australian Productivity Commission's review into compulsory licensing in the patents system is now…

Asia-PacificBiotechnologyLicensingPatentsPharmaceutical

PharmaEngine and Nanobiotix sign Asia-Pacific deal for NBTXR3

08-08-2012

French nano-medicines group Nanobiotix has entered into a strategic partnership with PharmaEngine (TWO:…

Asia-PacificBiotechnologyLicensingNanobiotixNBTXR3OncologyPharmaceuticalPharmaEngine

Alnylam and Ascletis collaborate to develop ALN-VSP for liver cancers in China

15-07-2012

US RNAi therapeutics specialties Alnylam Pharmaceuticals (Nasdaq: ALNY) and Ascletis Pharmaceuticals,…

ALN-VSPAlnylam PharmaceuticalsAscletis PharmaceuticalsAsia-PacificBiotechnologyLicensingOncology

1 to 25 of 34 results

Back to top